Number of the records: 1  

Targeting nanoparticles to modulate mTOR activity in cancer cells

  1. 1.
    0498007 - FZÚ 2019 GB eng A - Abstract
    Lunova, M. - Prokhorov, Andriy - Jirsa, M. - Hof, Martin - Olžyńska, Agnieszka - Jurkiewicz, Piotr - Kubinová, Šárka - Lunov, Oleg - Dejneka, Alexandr
    Targeting nanoparticles to modulate mTOR activity in cancer cells.
    FEBS Open Bio. Wiley. Roč. 8, July (2018), s. 93-94. ISSN 2211-5463. E-ISSN 2211-5463
    R&D Projects: GA MŠMT(CZ) LO1409; GA MŠMT(CZ) LM2015088
    Institutional support: RVO:68378271 ; RVO:61388955 ; RVO:68378041
    Keywords : mesoporous silica nanoparticles * iron-oxide nanoparticles * double-stranded-rna * drug-delivery
    OECD category: Condensed matter physics (including formerly solid state physics, supercond.); Polymer science (UFCH-W); Biophysics (UEM-P)

    Cancer is a major public health problem worldwide and is the second leading cause of death in the world. In recent years, there has been an unprecedented expansion in the field of nanomedicine with the development of new nanoparticles for the diagnosis and treatment of cancer. Yet, we still possess incomplete understanding of nano–bio interactions on ellular and molecular.levels. Such gap in the knowledge creates hurdles for clinical translation and commercialization of nanomedicines. Here we demonstrate that amino-functionalized polystyrene nanoparticles trigger cell death in hepatocellular carcinoma cells.
    Permanent Link: http://hdl.handle.net/11104/0290433

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.